Connecting to SEC EDGAR… PricingSign in
← All filings

NMRA

Neumora Therapeutics, Inc. SEC filings
Biological Products, (No Diagnostic Substances) · Nasdaq · Incorporated in DE
On the radar right now · 0
Nothing in the live feed for NMRA right now.
Filing history
2026-10-30
Current report 8-K
Listing notice (delisting or exchange move)
Filing ↗
2026-08-21
Insider trade 4
Filing ↗
2026-08-21
Insider trade 4
Filing ↗
2026-08-21
Insider trade 4
Filing ↗
2026-08-21
Insider trade 4
Filing ↗
2026-08-21
Insider trade 4
Filing ↗
2026-08-21
Planned insider sale 144
Filing ↗
2026-08-20
Planned insider sale 144
Filing ↗
2026-08-19
Insider trade 4
Filing ↗
2026-08-19
Planned insider sale 144
Filing ↗
2026-08-18
Planned insider sale 144
Filing ↗
2026-08-17
Planned insider sale 144
Filing ↗
2026-08-14
Quarterly report 10-Q
Filing ↗
2026-08-14
Current report 8-K
Earnings resultsExec/director change
Filing ↗
2026-07-27
Current report 8-K
Other event
Filing ↗
2026-06-15
Current report 8-K
Material agreementNew debtLayoffs/restructuringReg FD disclosureOther event
Filing ↗
2026-05-29
Insider trade 4
Filing ↗
2026-05-29
Insider trade 4
Filing ↗
2026-05-29
Insider trade 4
Filing ↗
2026-05-29
Insider trade 4
Filing ↗
2026-05-29
Insider trade 4
Filing ↗
2026-05-29
Current report 8-K
Shareholder vote
Filing ↗
2026-05-15
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-05-07
Quarterly report 10-Q
Filing ↗
2026-05-07
Current report 8-K
Earnings results
Filing ↗
2026-05-04
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-04-17
Proxy material DEFA14A
Filing ↗
2026-04-17
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-04-01
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-03-30
Employee stock plan shares S-8
Filing ↗
2026-03-30
Annual report 10-K
Filing ↗
2026-03-30
Current report 8-K
Earnings results
Filing ↗
2026-02-19
Insider trade 4
Filing ↗
2026-02-19
Insider trade 4
Filing ↗
2026-02-19
Insider trade 4
Filing ↗
2026-02-19
Insider trade 4
Filing ↗
2026-02-19
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-02-17
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-02-17
Planned insider sale 144
Filing ↗
2026-02-17
Planned insider sale 144
Filing ↗